Dr. Gil Hoftman is an Assistant Professor at UCLA Psychiatry, an attending physician in the TMS clinic, and Medical Co-Director for the Center for the Assessment and Prevention of Psychosis Risk Syndromes. Specializing in Child & Adolescent Psychiatry, he focuses on understanding and treating psychosis risk states, including the use of Transcranial Magnetic Stimulation (TMS) for these conditions. Dr. Hoftman integrates holistic, personalized care with a developmental and neurobiological perspective, considering environmental and psychological factors in his approach.
Dr. Hoftman leads research in psychosis, schizophrenia, and neurodevelopment, using advanced techniques like imaging transcriptomics. His work is supported by prestigious organizations, aiming to connect molecular disruptions in neural circuitry to human brain development. He is Board Certified in both General Adult Psychiatry and Child & Adolescent Psychiatry, offering evidence-based TMS treatment for depression and other conditions.
